Covinnovations™ Seeks $25m For COVID-19 Treatments
Covinnovations™, a Las Vegas-based developer of later-stage COVID-19 treatments, is looking to raise USD 25m, interim CEO Kristine Leavitt told Mergermarket during the Biotech Showcase Conference.
Previous
Previous
How Will We Stop the Impacts of COVID
Next
Next